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Abstract
Background: Lymph node metastasis (LNM) of gastric cancer is an important prognostic factor regarding long-
term survival. But several imaging techniques which are commonly used in stomach cannot satisfactorily assess the
gastric cancer lymph node status. They can not achieve both high sensitivity and specificity. As a kind of machine-
learning methods, Support Vector Machine has the potential to solve this complex issue.
Methods: The institutional review board approved this retrospective study. 175 consecutive patients with gastric
cancer who underwent MDCT before surgery were included. We evaluated the tumor and lymph node indicators on
CT images including serosal invasion, tumor classification, tumor maximum diameter, number of lymph nodes,
maximum lymph node size and lymph nodes station, which reflected the biological behavior of gastric cancer.
Univariate analysis was used to analyze the relationship between the six image indicators with LNM. A SVM model was
built with these indicators above as input index. The output index was that lymph node metastasis of the patient was
positive or negative. It was confirmed by the surgery and histopathology. A standard machine-learning technique called
k-fold cross-validation (5-fold in our study) was used to train and test SVM models. We evaluated the diagnostic
capability of the SVM models in lymph node metastasis with the receiver operating characteristic (ROC) curves. And the
radiologist classified the lymph node metastasis of patients by using maximum lymph node size on CT images as
criterion. We compared the areas under ROC curves (AUC) of the radiologist and SVM models.
Results: In 175 cases, the cases of lymph node metastasis were 134 and 41 cases were not. The six image indicators all
had statistically significant differences between the LNM negative and positive groups. The means of the sensitivity,
specificity and AUC of SVM models with 5-fold cross-validation were 88.5%, 78.5% and 0.876, respectively. While the
diagnostic power of the radiologist classifying lymph node metastasis by maximum lymph node size were only 63.4%,
75.6% and 0.757. Each SVM model of the 5-fold cross-validation performed significantly better than the radiologist.
Conclusions: Based on biological behavior information of gastric cancer on MDCT images, SVM model can help
diagnose the lymph node metastasis preoperatively.
Background
Gastric cancer is one of the leading causes of cancer-
related deaths worldwide [1]. Lymph node status is an
important prognostic factor regarding long-term survival
[2]. The TNM staging system based on American Joint
Committee on Cancer (AJCC) is accepted widely now [3].
T h e5 - y e a rs u r v i v a lr a t eo fp a t i e n t si nt h eN 0s t a g ea f t e r
surgery was 86.1%, while the N1, N2, and N3 stage patients
dropped to 58.1%, 23.3% and 5.9%, respectively [4].
At present, many imaging techniques have been used to
assess gastric cancer, including abdominal ultrasound,
endoscopic ultrasound (EUS), multi-slice spiral CT, con-
ventional MRI, and FDG-PET. However, these imaging
methods cannot reliably confirm or exclude the presence
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any medium, provided the original work is properly cited.of lymph node metastasis [1]. A meta-analysis showed that
the average sensitivity and specificity in determining LN
metastasis were as follows: 39.9% and 81.8% for abdominal
ultrasound, 70.8% and 84.6% for endoscopic ultrasonogra-
phy, 80.0% and 77.8% for MDCT, 68.8% and 75.0% for
conventional MRI, 34.3% and 93.2% for FDG-PET, and
54.7% and 92.2% for FDG-PET/CT [2]. Any single applica-
tion of these imaging tools cannot satisfactorily assess the
gastric cancer lymph node status. The reason is that we
mainly diagnose LNM by the size of lymph nodes. The
diagnostic criteria range from 5 mm to 10 mm [2]. But the
large lymph nodes may be caused by inflammation and
the small lymph nodes may be metastatic. Many studies
have shown that gastric cancer LN metastasis was asso-
ciated with tumor size, depth of invasion, histological type
and pathological lymphatic involvement [5-8]. There is no
suitable method to combine lymph node size with the
multiple factors described above to make a comprehensive
analysis. How to integrate the complex factors affecting
lymph nodes and improve the accuracy of diagnosing
LNM is the topic of our study.
In the past decade, machine-learning methods, com-
plementary to traditional statistical methods, have been
used to predict complex biological phenomena. Support
Vector Machine is a new generation of learning algo-
rithms developed on the basis of statistical theory. The
SVM algorithm has a strong theoretical foundation,
based on the ideas of VC (Vapnik Chervonenkis) dimen-
sion and structural risk minimization. It has satisfied
accuracy [9]. SVM has been used in some medical appli-
cations, mainly in molecular biology and neuroimaging
[10-12]. It can be used for classification and regression.
Given a set of training examples, each marked as
belonging to one of two categories, a SVM training algo-
rithm builds a model that predicts whether a new exam-
ple falls into one category or the other.
The purpose of this study is to use SVM method to
analyze the MDCT imaging information related to the
biological behavior of gastric cancer and establish the
mathematical models to assess lymph node metastasis
preoperatively.
Methods
Patients
This retrospective study was approved by our institu-
tional review board. Between April 2006 and September
2008, 368 consecutive patients with newly diagnosed
gastric cancer were administered preoperative contrast
enhancement abdominal CT examinations and then
received the gastrectomy at our hospital. The patients
corresponded to the inclusion and exclusion criteria
below were included in this study.
Inclusion criteria
The patients received radical gastrectomy and D2 lymph
nodes dissection. They were preoperatively examined
with multi- detector row CT. All patients were con-
firmed as gastric cancer by postoperative histopathology.
Exclusion criteria
The patients received preoperative neoadjuvant therapy.
Distant metastasis was found in the preoperative exami-
nation or in the operation.
Finally, 175 patients (125 males, 50 females, mean age,
59.8 years; range, 30-85 years) comprised our study
population. We obtained informed consent from all
selected patients prior to the routine clinical course of
CT examinations.
CT Protocol
MDCT was performed using a 64-detector row CT
scanner (LightSpeed 64; GE Healthcare, Milwaukee,
Wis). Each patient fasted for more than 8 hours before
the CT examination. To enable gastric distention and
reduce gastric motility, the patients received 8 g gas-
producing crystals orally and an intramuscular injection
of 10 mg anisodamine 10-15 minute before the exami-
nation. Upper abdominal unenhanced CT scans from
the diaphragmatic domes to 2 cm below the lower mar-
gin of the air-distended gastric body were acquired with
a collimation of 0.625 mm, 120-140 kVp, and 300-350
mAs. Subsequently, a total of 100 ml of iopromide
(Ultravist; Schering, Berlin, Germany) was administered
intravenously through an 18-gauge angiographic cathe-
ter inserted into an antecubital vein at 3 mL/sec by
using an automatic injector. Contrast-enhanced CT
scans were performed in the arterial phase (30 seconds)
and in the portal venous phase (70 seconds). We made
the multi-planar reconstruction with the portal venous
phase image.
Image Analysis
Two radiologists, one with 3 yrs and the other with
8 yrs experience in abdominal CT performed image ana-
lyses jointly to agreement. If there was disagreement,
they consulted with another radiologist who had 20 yrs
experience in abdominal CT until agreement was
achieved. We measured and counted the six indicators
on MDCT images by hands as follows:
Tumor maximum diameter
Measure the diameter of gastric cancer in the axial, cor-
onal, and sagittal images based the MPR images. And
decide the tumor maximum diameter.
Tumor classification
Early gastric cancer or Borrmann classification of
advanced cancer in the MPR images was determined.
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Axial and MPR images were simultaneously evaluated to
determine the serosal invasion. The entire thickening
stomach wall abnormally enhanced and linear or reticu-
lar structures in the fatty layer surrounding the stomach
indicated serosal invasion [13].
Number of lymph nodes
The number of all the visible gastric regional lymph
nodes in the MDCT images by groups was counted [14].
Maximum lymph node size
The short axis of the largest lymph node detected in CT
images was measured.
Lymph nodes station
The lymph nodes station with MDCT images based on
the Japanese classification of gastric carcinoma was
determined [14].
Support vector machine
Support Vector Machine is a supervised machine learn-
ing technique that is widely used in pattern recognition
and classification problems. SVM algorithm performs a
classification by constructing a multidimensional hyper-
plane that optimally discriminates between two classes
by maximizing the margin between two data clusters.
This algorithm achieves high discriminative power by
using special nonlinear functions called kernels to trans-
form the input space into a multidimensional space
[15]. In this study, a free available SVM software called
LibSVM 2.89 was used to generate the SVM model [16].
The input indexes were the six indicators collected on
MDCT images above. For these indicators, the measure-
ment data could be entered to SVM model directly.
While the count data should be defined as some num-
bers. For example, positive serosal invasion was defined
as 1 and negative was -1. The output index was the
lymph node metastasis of the patient. It was confirmed
by the surgery and histopathology. If the patient had
one or more lymph nodes metastasis, it was considered
as positive LNM. We defined the positive LNM as 1
while the negative was -1. We selected the RBF Kernel
to build the model. To train and test our SVM model,
we used a standard machine-learning technique called
k-fold cross-validation. Because the whole sample size of
our study was not very large, we used 5-fold cross-vali-
dation. The whole data were divided into 5 equal and
distinct subsets. Four of these subsets are combined and
used for training, and the remaining one set is used for
testing. This cross-validation process was repeated 5
times, allowing each subset to serve once as the test
data set.
Statistical Analysis
A univariate statistical analysis using the SPSS/PC+ statis-
tical software package version 11.5 (SPSS Inc, IL, Chicago,
USA) was performed to evaluate the differences of six
imaging indicators between the patients who had LNM or
not. The statistical analysis methods were the Indepen-
dent-samples T test and Mann-Whitney U test. P < 0.05
was considered significant difference. Receiver operating
characteristic (ROC) curve was used to evaluate the diag-
nostic performance of the SVM model. The Medcalc soft-
ware version 11.2 (Medcalc, Medcalc Software, Ghent,
Belgium) was used to make the ROC curves and compare
them. In summary, we averaged the area under the curve
(AUC) of the ROC curves of the 5-fold cross-validation.
We also counted the means of sensitivity and specificity.
To compare with the SVM model, we constructed the
ROC curve for radiologist assessment by using maximum
lymph node size as criteria to classify the LNM. The sensi-
tivity and specificity of the best cut-off point were counted.
Results
In these 175 cases, there were 134 cases which had
lymph node metastasis and 41 cases had not. Patients’
clinicopathological features were detailed at the Table 1.
We collected the six indicators on MDCT images. The
results of the univariate statistical analysis indicated that
the all six indicators including serosal invasion, tumor
classification, tumor maximum diameter, number of
lymph nodes, maximum lymph node size and lymph
nodes station were significant different between the
LNM positive and negative group (P < 0.001). The
means of tumor maximum diameter, number of lymph
nodes, and maximum lymph node size in LNM positive
group were 56.6 ± 19.5 mm, 10.0 ± 5.5 mm, and 12 ± 8,
r e s p e c t i v e l y .T h e yw e r ea l lh i g h e rt h a nt h o s eo fL N M
negative group (Table 2).
The radiologist achieved an AUC of 0.757 as classify-
ing lymph node metastasis of the patient by maximum
lymph node size. The best cut-off point of maximum
l y m p hn o d es i z ew a s7 . 7m m .T h es e n s i t i v i t ya n d
Table 1 Patient Characteristics
Clinicopathological features Value
No. of patients 175
Mean age (y) 59.8(30-85)
Ratio of women to men 50:125
Histopathology
Adenocarcinoma 173(98.9%)
Well differentiated 6(3.4%)
Moderately differentiated 91(52%)
Poorly differentiated 76(43.5%)
Small cell carcinoma 2(1.1%)
lymph node metastasis
Positive 134(76.6%)
Negative 41(23.4%)
Note.–Numbers in parentheses are the ranges.
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means of the sensitivity, specificity and AUC with 5-fold
cross-validation were 88.5%, 78.5% and 0.876, respec-
tively (Table 3). Compared to the radiologist, each AUC
of the 5-fold cross-validation SVM models performed
significantly better (P < 0.05) than the radiologist (Figure
1,Table 3).
Discussion
Lymph node metastasis affects the surgical treatment of
patients with gastric cancer and is also an important fac-
tor in prognosis. At present, preoperative diagnosis
mainly depends on various imaging methods. The stan-
dard for judging lymph node metastasis relies on mor-
phological indicators. Lymph node size is the dominant
indicator. However, Dorfman RE et al reported that
upper limits of normal for lymph node size at abdom-
inal computed tomography varied from 6 to 11 mm
[17]. They partly overlapped with the malignant lympha-
denopathy. Fukuya T et al showed that CT attenuation
and lymph-node configuration could aid in diagnosis of
malignant adenopathy [18]. On the contrary, Deutch SJ
et al expressed that size, location, contour, density were
not helpful in distinguishing benign from malignant
lymphadenopathy [19]. Lack of criteria for judging is the
main constraint for the prediction of lymph node metas-
tasis preoperatively.
Table 2 Patient data: The 6 indicators’ data of the MDCT
images and the results of univariate statistical analysis
Patient data LNM(-) LNM(+) P
value
Patient number 41/175
(23.4%)
134/175
(76.6%)
Measurement data*
Tumor maximum diameter
(mm)
39.0 ± 17.0 56.6 ± 19.5 <0.001
Maximum lymph node size
(mm)
6.5 ± 2.8 10.0 ± 5.5 <0.001
Number of lymph nodes 7 ± 4 12 ± 8 <0.001
Count data#
Serosal invasion <0.001
Yes 15/175
(8.6%)
120/175
(68.6%)
No 26/175
(14.8%)
14/175(8%)
Tumor classification <0.001
Early gastric cancer 9/175(5.1%) 1/175(0.6%)
BorrmannI 2/175(1.1%) 0/175
BorrmannII 3/175(1.7%) 9/175(5.1%)
Borrmann III 27/175
(15.4%)
121/175
(69.1%)
Borrmann IV 0/175 3/175(1.7%)
Lymph nodes station <0.001
Station1 29/175
(16.6%)
44/175
(25.1%)
Station2 12/175
(6.9%)
54/175
(30.9%)
Station3 0/175 36/175(20.5)
* The value of the measurement data was means ± standard deviation. The p
value was from Independent-samples T test.
# The value of the count data was the number of data. The p value was from
Mann-Whitney U test.
Table 3 AUC of SVM model and radiologist
Model K-fold Sensitivity Specificity AUC* P value (AUC compared with Radiologist)
SVM K1 0.881 0.780 0.862 ± 0.038 0.002
K2 0.866 0.780 0.866 ± 0.037 <0.001
K3 0.858 0.805 0.878 ± 0.033 <0.001
K4 0.933 0.780 0.900 ± 0.031 <0.001
K5 0.888 0.780 0.876 ± 0.038 <0.001
mean 0.885 0.785 0.876
Radiologist 0.634 0.756 0.757 ± 0.042
The sensitivity, specificity and AUC of 5-fold cross-validation SVM models and radiologist for diagnosing lymph node metastasis of patient.
* The value of the data was AUC ± standard deviation.
Figure 1 ROC curve for LNM. Receiver operating characteristic
(ROC) curve for lymph node metastasis with 5-fold cross-validation
SVM models and radiologist. The AUC of k1 to k5 SVM models were
0.862, 0866, 0.878, 0.900 and 0876, respectively. Compared with the
radiologist, the P values were all less than 0.05 (Table 3). For the five
SVM models, the mean of AUCs was 0.876. And the AUC of
radiologist based LN size was 0.757.
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histopathological performance of the tumor’sm a l i g -
nance and invasion. It affects lymph node metastasis
directly or indirectly. The concrete manifestation of the
biological behavior includes, for example, tumor size,
depth of invasion, tumor invasion of other organs,
lymph node metastasis and distant metastasis. MDCT
can clearly display these pathological occurrences. Some
studies have reported that the accuracy of gastric cancer
T staging with MDCT combined with 3D reconstruction
was 84-89% [20,21]. Zhang XP et al reported that the
number of lymph nodes detected by MDCT showed a
significant difference between the lymph node metastasis
group and no metastasis group in cardiac cancer [22].
MDCT can also indicate the situation in other abdom-
inal organs and the peritoneum. Therefore, MDCT ima-
ging can accurately reflect the biological behavior of
gastric cancer histopathology. Univariate analysis in our
study showed that the 6 indicators of gastric cancer and
lymph nodes information on CT images all have a rela-
tion to LNM. So we should consider these biological
behaviour factors comprehensively in predicting LNM.
There were some other machine-learning methods
used in medical studies. The mainly method was artifi-
cial neural network (ANN). ANN is considered to be an
appropriate method for medical data analysis [23].
Bollschweiler et al applied a single-layer perceptron,
which is a kind of ANN, to predict lymph node metasta-
sis in gastric cancer. The accuracy of ANN was 79%
[24]. However, the ANN had some disadvantages.
ANN’s model was prone to overfitting. It required
lengthy development and time to optimize. They were
more difficult to use in the field because of computa-
tional requirements [25]. In consideration of the above
reasons, we selected the SVM model instead. The SVM
could produce lower prediction error compared to clas-
sifiers based on other methods like artificial neural net-
works [26]. Compared with ANN, SVM may have the
same even better predictive ability [27,28]. At present,
there are few reports about the application of SVM in
gastric cancer lymph node metastasis. As a preliminary
study, our results indicate that SVM model has better
diagnostic capability for LNM than the traditional LN
size criteria. The AUC has achieved a good diagnostic
power. With further improvement, SVM may become
an effective method to predict lymph node staging of
gastric cancer.
Conclusions
Based on biological behavior information of gastric can-
cer on MDCT images, SVM model can help diagnose
the lymph node metastasis preoperatively.
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